Marshall University

Marshall Digital Scholar
Faculty Research

Marshall Institute for Interdisciplinary Research

4-1-2012

Chronic Paracetamol Treatment Influences Indices
of Reactive Oxygen Species Accumulation in the
Aging Fischer 344 X Brown Norway Rat Aorta
Kevin M. Rice
Marshall University, rice9@marshall.edu

Sarath Meduru
Marshall University

Sunil K. Kakarla
Marshall University, kakarla@marshall.edu

Anjaiah Katta
Marshall University, katta@marshall.edu

Sriram P. Mupparaju
Marshall University
See next page for additional authors

Follow this and additional works at: http://mds.marshall.edu/miir_faculty
Part of the Biological Phenomena, Cell Phenomena, and Immunity Commons
Recommended Citation
Rice KM, Meduru S, Kakarla SK Katta A, Mupparaju SP, Kidd B, Goebel, LJ Blough ER. (2012) Chronic paracetamol treatment
influences indices of reactive oxygen species accumulation in the aging Fischer 344 x Brown Norway rat aorta. Ann Clin Lab Sci
42(2):152-161.

This Article is brought to you for free and open access by the Marshall Institute for Interdisciplinary Research at Marshall Digital Scholar. It has been
accepted for inclusion in Faculty Research by an authorized administrator of Marshall Digital Scholar. For more information, please contact
zhangj@marshall.edu.

Authors

Kevin M. Rice, Sarath Meduru, Sunil K. Kakarla, Anjaiah Katta, Sriram P. Mupparaju, Brent Kidd, Lynne J.
Goebel, and Eric R. Blough

This article is available at Marshall Digital Scholar: http://mds.marshall.edu/miir_faculty/35

Available online at www.annclinlabsci.org
152

Annals of Clinical & Laboratory Science, vol. 42, no. 2, 2012

Chronic Paracetamol Treatment Influences Indices of
Reactive Oxygen Species Accumulation in the
Aging Fischer 344 X Brown Norway Rat Aorta
Kevin M. Rice 1, Sarath Meduru 1, Sunil K Kakarla2, Anjaiah Katta2, Sri ram P. Mupparaju 1, Brent Kidd1,
Lynne J. Goebel 3, and Eric R. Blough 1· 4
1 Center for Diagnostic Nanosystems, Marshall University, Huntington WV; 2 Department of Pharmacology, Physiology
and Toxicology, Joan C. Edwards School of Medicine, Marshall University, Huntington WV; 3 Department oflnternal
Medicine and Geriatrics, Joan C. Edwards School of Medicine, Marshall University, Huntington WV; 4 Department of
Pharmaceutical Science and Research, School of Pharmacy, Marshall University, Huntington, WV

Abstract. Previous reports have demonstrated that increased levels of reactive oxygen species (ROS) and
alterations in cell signaling characterize aging in the Fischer 344 X Brown Norway (FBN) rat aorta. Other
work has suggested that increases in ROS may be related to vascular wall thickening and the development
of hypertension. Paracetamol (acetaminophen) is a potent antioxidant that has been found to diminish
free radicals in ischemia-reperfusion studies. However, it remains unclear whether chronic paracetamol
administration influences signaling or ROS accumulation in the aging aorta. FBN rats (27 months old;
n=8) were subjected to 6 months of treatment with a therapeutic dose of paracetamol (30 mg/kg/day) and
compared to age-matched untreated FBN rat controls (n=8). Compared to measurements in the aortae of
6-month old animals, tunica media thickness, tissue superoxide levels, and protein oxidation levels were
38 ± 7%, 92 ± 31 o/o, and 7 ± 2% higher in the aortae of 33-month control animals (p <:;,0. 05). Chronic
paracetamol treatment decreased tunica media thickness and the amount of oxidized protein by 13 ± 4%
and 30 ± 1o/o, respectively (p <:;,0. 05). This finding of diminished aortic thickening was associated with increased phosphorylation (activation) of the mitogen activated protein kinases and diminished levels of the
anti-apoptotic protein Bcl-2. Taken together, these data suggest that chronic paracetamol treatment may
decrease the deleterious effects of aging in the FBN rat aorta
Keywords: aging; aorta; paracetamol; ROS; cell signaling

Introduction
It is estimated that by the year 2035, nearly one in
four individuals will be 65 years of age or older [1].
Since cardiovascular diseases -such as coronary artery disease, peripheral vascular disease, hypertension, and chronic heart failure - are more prevalent
among older persons, understanding why aging
may be associated with increased incidence of cardiovascular disease will perforce take on greater
significance [1]. An emerging hypothesis, described
as the free radical theory of aging, suggests that
Address correspondence to Eric Blough; Center for Diagnostic
Nanosystems; Room 241N, Robert C. Byrd Biotechnology Science
Center Building; Department of Pharmaceutical Science and Research;
1700 3rd Ave. Marshall University; Huntington, WV 25755-1090;
e-mail: blough@marshall.edu

aging occurs through the gradual accumulation of
free radical damage to biomolecules [2]. Inherent
to this theory is that oxidative stress (often measured by alterations in levels of serum protein C,
TNF-alpha and other cytokines) increases with advancing age. It is thought that oxidative stress both
promotes and is induced by vascular disease and
risk factors that lead to vascular disease.
Paracetamol (acetaminophen) is one of the most
widely used of all drugs, with a wealth of experience clearly establishing it as the standard antipyretic and analgesic for mild to moderate pain.
Recent ischemia-reperfusion work has suggested
that paracetamol exhibits antioxidant properties
that may be cardia-protective and anti-arrhythmic
under conditions of increased oxidative stress [3].
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Whether paracetamol might offer protection
against the effects of age-associated increases in
vascular oxidative stress is currently unclear.
Previous work by our laboratory has reported that
aging in the Fischer 344 X Brown Norway (FBN)
rat aorta is characterized by increased levels of reactive oxygen species (ROS) and alterations in the
regulation of the stress-activated signaling molecule adenosine monophosphate-activated protein
kinase (AMPK), the apoptotic regulators Bax and
Bcl-2, and the mitogen-activated protein kinases
(MAPK) [4]. These data are important given that
these molecules and pathways may be involved in
regulating vascular smooth muscle growth, which
can give rise to increases in vessel thickness and
blood pressure if allowed to proceed unregulated.
Additional studies have demonstrated that the
function and activity of specific MAPKs such as
p38 kinase, extracellular-signal-regulated kinase
1/2 (ERK 1/2-p44/p42), as well as the c-Jun
N-terminal kinase (JNK), have been found to be
regulated by ROS in vascular tissues [5-7]. While
other research has demonstrated that paracetamol
is involved in the regulation of the MAPKs and
apoptosis in hepatocytes [8-10], how paracetamol
may regulate these molecules in the aging aorta
has, to our knowledge, not yet been investigated.
Therefore, the purpose of this study was to determine how aging and paracetamol treatment alter
the production of ROS and markers of oxidative
stress in the aging FBN rat aorta. We hypothesized
that chronic treatment with therapeutic doses of
paracetamol would result in a diminished age-associated increase in aortic ROS and activation of
stress-activated signaling.
Materials and Methods

Animals. All procedures were performed in accordance with the Marshall University Institutional
Animal Care and Use Committee (IACUC) guidelines, using the criteria outlined by the American
Association of Laboratory Animal Care (AALAC)
as set forth in the Animal Welfare Act (PL89-544,
PL91-979, and PL94-279). Fischer 344/NNiaHSD
x Brown Norway/BiNia (FBN) rats aged 6 and 27
months, were purchased from the National
Institute on Aging colony at Harlan. Animals were
housed two per cage m an AALAC
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approved vivarium with a 12 hour light-dark cycle
and a temperature maintained at 22 ± 2°C, and fed
ad libitum. All animals were allowed to acclimatize
for two weeks before initiation of any treatment or
procedures. All animals were examined for precipitous weight loss, failure to thrive, or unexpected
gait alterations, and animals with apparent abnormalities or tumors were removed from the study.
Periodic weight measurements were taken throughout the duration of the study.

Materials. Acetaminophen tablets or pure compound used in the study was provided by McNeil
PA).
Pharmaceuticals
(Fort
Washington,
Antibodies against Bax, Bcl-2, and mouse lgG,
goat lgG, and rabbit lgG antibodies were purchased from Santa Cruz Biotechnology, Inc. (Santa
Cruz, CA). Antibodies against AMPK-a,
p44/42(ERK1/2-MAPK), p38-MAPK, SAPK/
JNK- MAPK, p-AMPK-a (Thr 172), p-p44/42 (Thr
202/Try 204), p-p38 (Thr 180/Try 182), p-SAPK/JNK
(Thr 183/Tyr 185), biotinylated protein ladder, and
mouse and rabbit lgG antibodies were purchased
from Cell Signaling Technology (Beverly, MA).
Precast 10% SDS-PAGE gels were procured from
Cambrex Biosciences (Baltimore, MD). Enhanced
chemiluminescence (ECL) western blot detection
reagent was acquired from Amersham Biosciences
(Piscataway, NJ). Restore western blot stripping
buffer was obtained from Pierce (Rockford, IL),
and 3T3 cell lysates were from Santa Cruz
Biotechnology (Santa Cruz, CA). All other chemicals were purchased from Sigma (StLouis, MO).
Chronic paracetamol treatment. 27-month old
FBN rats (n=8) were subjected to 6 months- thus,
up to the age of 33 months - of treatment with 30
mg/kg/day of acetaminophen administered
through drinking water. Age-matched FBN control animals (n=8) were maintained under the same
environmental conditions without any drug
treatment.
Aortic specimen collection. Rats were anesthetized with a ketamine-xylazine (4:1) cocktail (50
mg/kg IP) and supplemented as necessary for reflexive response. In a sterile environment, the ventral surface of the thorax was shaved and the superficial musculature was exposed by means of a
transverse incision through the skin distal to the
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hematoxylin and eosin, mounted,
and cover-slipped. Morphometric
evaluation was performed with the
use of a computerized imaging analysis system (Image J). Medial thickness in micrometers was calculated
from the average of eight different
6mon
33 mon con 33 mon APAP points of cross section. H ydroethidine
(HE), an oxidative fluorescent dye,
100.0
was used to visualize superoxide production in situ [11, 12]. HE is permeT
to cells and in the presence of
able
:::1. 80.0
T
superoxide (0 2 · -) is oxidized to
I I)
II)
Ethidium bromide, where it intercaQJ 60.0
lates
unable DNA [13]. Because
c
.:.:
Ethidium
is unable to cross the cell
(.)
membranes, extracellular 0 2 ·
..c 40.0
would not be expected to significant.~
ly contribute to the observed cellular
20.0
fluorescence [14]. Since neither hyQJ
:E
droxyl radical, 'NO, peroxynitrite,
H 2 0 2 , hypochlorite, nor singlet 0 2
0.0
significantly oxidizes HE, an increase
6mon
33mon con
33monAPAP
in Et fluorescence is thought to specifically indicate 0 2 . - generation
Figure I. Aortic medial thickness is altered with aging and
paracetamol treatment in F344/N X BN rat. The mediar thickness
within the fluorescing cell. Briefly,
of aortae from 6-month and 33-month old control and 33-month
aortic sections were incubated for 30
paracetamol-treated rats. Data are presented as means ± SE. Insets:
rep~esentative H & E stained aortic sections. (*) indicates significant
min at 37"C with 5mM HE. After
diHerence from adult (6-month old) value (P<0.05). (t) indicates sigextensive washing with PBS and
nificant difference from the 33-month old control value (P<0.05). n =
8 for all groups. Scale Bar = 50 11m.
mounting (permount), tissue was visualized under fluorescence using an
Olympus fluorescence microscope
(Melville, NY) and analyzed using imaging softthoracic cavity. After midline laparotomy and perware (AlphaEaseFC). The intensity of fluorescent
foration of the heart, the aorta was isolated and reEt-stained nuclei was calculated by digitizing immoved from its origin at the left ventricle to the
ages and then determining the average pixel intenrenal arch and placed in Krebs-Ringer bicarbonate
sity of six randomly positioned regions (1000 mm 2)
buffer (KRB) containing 118mM NaCl, 4.7mM
per arterial cross section. Six images per vessel were
KC1, 2.5mM CaC1 2 , 1.2mM KH 2 PO 4 , 1.2mM
analyzed with :e:500 nuclei per vessel examined.
MgS0 , 24.2mM NaHC0 and 10mM a-D-glu-

-E
-

*

*t

T

·-...

,
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cose, (pH 7.4) equilibrated with 5% C0 2 I 95o/o 0 2
and maintained at 37"C. Isolated aortae were
cleaned of connective tissue, weighed and immediately snap frozen in liquid nitrogen.
Histology and oxidative fluorescent microscopy.
Aortic specimens were serially sectioned (8 11m) using an IEC Microtome cryostat and collected on
poly-lysine coated slides. After fixing in acetone
(22aC for 2 min), sections were stained with

Immunoblot analysis. Tissues were pulverized in
liquid nitrogen using a mortar and pestle until a
fine powder was obtained. After washing with icecold PBS, pellets were lysed on ice for 15 minutes in
T-PER (2mL/1g tissue weight) (Pierce, Rockford,
IL) and centrifuged for 10 minutes at 2000 X g to
pellet particulate matter. Protein concentrations of
homogenates were determined in triplicate via the
Bradford method (Pierce), using bovine serum
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albumin as a standard. Samples were
diluted to a concentration of 2.0flg/
f.!l in SDS loading buffer and boiled
for 5 min. 40 flg of total protein per
sample was separated on a 10%
SDSPAGE gel. Transfer of protein
onto nitrocellulose membranes was
performed using standard conditions [15]. To verify transfer of proteins and equal loading of lanes, the
membranes were stained with
Ponceau S.

6mon

33 mon con
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33 monAPAP

2.5

*
2.0
C1)

C)

l
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For immunodetection, membranes
r
c 1.5
ns
were blocked in 5% Milk TBST for
J:
1 h at room temperature and then
()
incubated with the appropriate priI
"C 1.0
mary antibody overnight. After
0
LL
washing in TBST, the membranes
were exposed to horseradish peroxi0.5
dase-labeled IgG (HRP) secondary
antibody for 1 h. Protein bands were
visualized with ECL (Amersham
0.0
Biosciences). Exposure time was adGmCON
33m CON
33mAPAP
justed to keep the integrated optical
Figure 2. Alterations in ROS with aging and paracetamol treatdensities (IODs) within a linear and
ment in F344/N X BN rat aortae. Detection ofvascular superoxide
non-saturated range. Band signal inby dihydroethidium (hydroethidine) with aging in the aortae of
6-month and 33-month old control and 33-montb old paracetamoltensity was quantified by densitomtreated F344/N X BN rats. The increase in su_peroxide involves all
etry using a flatbed scanner (Epson
L_1yers within the ve~sel wall.. Scale. Bar= 50f1m. Quantification of aortlc ROS as determmed by mtens1ty of fluorescent Et-stained nuclei.
Pefection 3200 PHOTO) and imag~esults are expressed as percent of the 6-month integrated optical dening
software
(AlphaEaseFC).
slty (100) value. An asterisk (*) indicates significant difference from
the 6-month old control value (P<0.05), (t) indicates significant differMolecular weight markers (cell sigence from the 33-month old control value (P<0.05). n = 8 for all
naling) were used as molecular mass
groups.
standards, and NIH 3T3 celllysates
were included as positive controls. A
OxyBlotTM Analysis. OxyBlot analysis was pertotal of three SDS-PAGE gels were run for each
formed, according to manufacturer's specifications
experimental set to evaluate changes in dependent
(Millipore, Billerica, MA), to identify carbonyl
variable tissue content and basal phosphorylation
groups
that are introduced into the amino acid side
where applicable. lmmunoblots were stripped with
chain after oxidative modification of proteins. The
restore western blot stripping buffer as described by
of protein oxidation was determined by an
level
the manufacturer to obtain direct comparisons beOxidized
Protein Detection Kit (OxyBlot,
tween expression and phosphorylation levels of difChemicon Cat# 57150-Kit). The OxyBlot kit deferent signaling molecules. After verifying the abrivatizes carbonyl groups to a 2, 4-dinitrophenylsence of residual HRP activity by treating the
(DNP) moiety. The DNP moiety can
hydrazone
membrane with the ECL reagent, membranes were
then
be
detected
using anti-DNP antibodies and is
washed and re-probed with HRP labeled antibody.
a method to assay for one form of oxidative damage
To minimize potential experimental error associto a protein. The proteins were derivatized as per
ated with membrane stripping, the order of antithe protocol given in the kit. These proteins were
body incubation was randomized between
separated on 10% SDS-PAGE gels and transferred
experiments.

-
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1.0
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membranes were washed in washing
buffer (TBS with 0.2% Tween-20).
Protein bands were visualized with ECL
(Amersham Biosciences). Band signal
intensity was quantified by densitometry
using a flatbed scanner (Epson Pefection
3200 PHOTO) and imaging software
(AlphaEaseFC).

"C

0

0.5

Statistical Methods. Results are pre-

L1.

0.0

6mCON

33m CON 33m APAP

sented as mean ± SEM. Statistical analyses were performed using Sigma Plot
11.2 statistical software. Comparisons
between morphologic indices and protein expression were evaluated by One
Way Analysis ofVariance (ANOVA) followed by a Student-Newman-Keuls
post-hoc analysis. The level of significance accepted a priori was~ 0.05.

Results

Aging is associated with increased
aortic wall thickness and evidence of
increased ROS. The tunica media
thickness in aortae from the 33-month
old control animals was 38 ± 7% higher
than that of the 6-month old control
animals (p~0.05) (Figure 1). Ethidium
Figure 3. Alterations in Protein oxidation with aging and
(Et) fluorescence was seen throughout
paracetamol treatment in F344/N X BN rat aortae. Protein iso1ates from the aortae excised from 6-month old and 33-month old
the aortic cross section with prominent
control and 33-month old paracetamol-treated F344/N X BN rats
signal in both the endothelial and mewere analyzed by immunob1ottin_g_for changes in protein oxidation.
Data are presented as means ± SE. Insets: representative blots for
dial portions (Figure 2). Compared to
protein oxidation. An asterisk (*) indicates significant difference
levels in the 6-month old control aniFrom the 6-month old control value, p < 0.05, (t) indicates s~gnifi
cant difference from the 33-month ofd control value (P<O. 05). n =
mals, superoxide levels, as determined
8 for all groups.
by the oxidation of HE to Et and the
quantification of Et fluorescence, were
91 ± 31% higher in the aortae of
33-month control animals (p ~ 0. 05) (Figure 2).
onto nitrocellulose membranes. After the transfer,
Similarly, protein oxidation as determined by the
membranes were blocked with 2.5% BSA (in Tris
OxyBlot assay was 7 ± 2% higher in the 33-month
Buffered Saline [TBS] with 0.2% Tween-20) for 1
old control animals (p ~0.05) (Figure 3).
h at room temperature. The nitrocellulose memTo
determine whether aging influenced the total
brane was exposed to a primary rabbit anti-DNPH
amount of AMPK-a present in the aorta, gel elecprotein antibody from Chemicon Oxyblot (1:200
trophoresis and immunoblot analysis using antiworking dilution) for 1 h, and then to a secondary
bodies
that recognize both the unphosphorylated
antibody [Goat Anti-Rabbit IgG
(HRPand phosphorylated forms of AMPK-a were perconjugated)] diluted in the blocking solution 1:500
formed. There were no differences between 6- and
for 1 h at room temperature. After every step,
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33-month old control aortae in the total content of
AMPK- a (data not shown). Compared to levels in
the 6-month old control animals, the basal phosphorylation levels of AMPK- a were 11 ± 6% lower
in the 33-month old control animals (p ~ 0. 05)
(Figure 4).

Aging is associated with changes in MAPK signaling and diminished expression of the apoptotic regulator Bax. The MAPK proteins play an
important role in propagating external stimuli into
the cytoplasm and nucleus. The p38-MAPK content was 19 ± 7% less in the 33-month old control
aortae than in the aortae from the 6-month old
animals (p < 0.05) (Figure 5). No change in the
total level of the p44 (ERK 1) - MAPK was observed with aging. However, the amount of p42
(ERK 2) - MAPK was 11 ± 3% lower in the
33-month old control aortae than in the 6- month
old control aortae (p ~0.05) (Figure 5). The JNK-1
MAPK levels in the 33- month old control aortae
were 19 ± 9% less than those found in the 6-month
old control aortae (p ~ 0. 05) (Figure 5), while JNK2 MAPK levels were 29 ± 5% lower in the 33-month
old control aortae compared to the 6-month old
control aortae. The JNK-3 MAPK levels in the
33-month old control aortae were not significantly
different from levels in the 6- month old control
aortae (Figure 5).
The phosphorylated p38- MAPK content in the
33-month old control aortae was 43 ± 12% less
than that observed in the 6-month old control aortae (p ~ 0. 05) (Figure 6). The activated levels of p44
(ERK 1) - MAPK and p42 (ERK 2) - MAPK in the
33-month old control aortae were 21 ± 3% and
26 ± 2% lower than those in the 6-month old control aortae, respectively (p ~0.05) (Figure 6). The
phosphorylated levels of JNK- 1 and JNK- 3
MAPKs were 25 ± 5% and 22 ± 3% less than that
found in 6-month old control animals (p ~ 0. 05)
(Figure 6).
With aging, the level of Bax expression decreased
by 28 ± 9% in the 33-month old control aortae
compared to in the 6-month old control aortae (p
~0.05) (Figure 7). Bcl-2 levels were not altered
with aging.
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Figure 4. Aging and paracetamol treatment alters
pliosphorylation status ofsignalingproteinAMPK a
in F344/N X BN rat aortae. Protein isolates from the
aortae excised from 6-month old and 33-month old
control and 33-month old paracetamol-treated F344/N
X BN rats were analyzed by immunoblotting for changes in phosphorylated AMPK a. Data are presented as
means ± SE. Insets: representative blots for phosphorylated AMPK a. An asterisk (*) indicates significant difference from the 6-month old control value, p < 0.05,
(t) indicates significant difference from the 33-month
old control value (P<O. 05). n = 8 for all groups.

Paracetamol treatment decreases age-associated
aortic thickening and protein oxidation. The tunica media thickness in the paracetamol-treated
aortae was 12 ± 4% less than that of the aortae
from the 33-month old control animals (p~0.05)
(Figure 1). No significant differences in the levels
of 0 2 · - were found between the 33-month old
control aortae and the paracetamol-treated aortae
(Figure 2). The levels of oxidized proteins as determined by OxyBlot assay were 30 ± 1o/o less in the
33- month paracetamol aortae (p ~0.05) (Figure
3).

Paracetamol treatment alters AMPK-a, p44p42 (ERK 1/2}-, p38-, and ]NK-MAPK signaling. There were no differences in the total content
of AMPK- a between the 33-month old control
and the 33- month old paracetamol-treated aortae
(data not shown). Compared to the levels of the 33month old control aortae, the basal phosphorylation levels of AMPK- a were 20 ± 6% more in the
33-month old paracetamol-treated aortae (p ~0.05)
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aortae were 14 ± 4% higher than in the 33-month
old control aortae (p <:;, 0. 05) (Figure 5).

1.5
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C)

~ 1.0
...c

r

u

"C 0.5

0

u..
6mCON
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33m APAP

p 38
p44
O p42
• Jnk 2
El Jnk 3
llllJ Jnk 1

a-Tubulin

F!gure 5. Aging and paracetamol treatment di.fferenttally affects the concentration ofproteins involved
in aortic signaling. Protein isolates from the aortae excised from 6-montb old and 33-month old control and
33-month old paracetamol-treated F344/N X BN rats
were analyzed by immunoblotting for changes in total
p44/p42 (ERK 1/2), p38 and Jnk protein expression.
Data are presented as means ± SE. insets: re2resentative
blots for total p44/p42 (ERK 1/2), p38 and Jnk. An asterisk (*) indicates significant difference from the
6-month old control va1ue, p < 0.05, (t) indicates significant difference from the 33-month old control value
(P<0.05). n = 8 for all groups.

(Figure 4). The p38- MAPK content in the
33-month old paracetamol-treated aortae was
24 ± 8% more than that seen in the aortae from the
33-month old control animals (p <:;,0.05) (Figure
5). The p44 and p42- MAPK levels are 20 ± 7%
and 18 ± 2% lower in the 33-month old paracetamoltreated aortae than in the 33-month old control
aortae, respectively (p <:;, 0. 05) (Figure 5). There was
no significant difference in the expression of total
JNK-1 MAPK levels between the 33-month old
control and the 33-month old paracetamol-treated
aortae (Figure 5). The JNK-2 MAPK levels in
paracetamol treated aortae were 22 ± 4% higher
than in the 33-month old control aortae (p <:;,0.05).
The JNK-3 MAPK levels in paracetamol-treated

The phosphorylated p38- MAPK content in the
33-month old paracetamol-treated aortae was not
significantly different than that in the 33-month
old control aortae (Figure 6). The activated levels
of p44 (ERK 1) - MAPK and p42 (ERK 2) - MAPK
were 26 ± 2% and 15 ± 2% higher with treatment,
respectively (p <:;,0.05) (Figure 6). Compared to
the levels in the 33-month old control animals, the
phosphorylated levels of JNK- 1 and JNK- 3
MAPKs were 16 ± 6% and 41 ± 3% higher in the
paracetamol-treated aortae (p <:;, 0. 05) (Figure 6).

Paracetamol treatment alters the regulation of
Bcl-2 but not Bax. The level of Bcl-2 protein was
decreased by 13 ± 4% in the 33-month old
paracetamol-treated animals compared to the
33-month old controls (p <:;,0.05) (Figure 7). Bax
levels were not altered with paracetamol
treatment.
Discussion

Previous work from our lab has suggested that aging is associated with increased levels of oxidative
stress [4]. Here we investigate if chronic paracetamol
treatment affects the regulation of previously identified indices of oxidative stress in the aging FBN
rat aorta. Our findings suggest that chronic treatment with a therapeutic dose of paracetamol alters
aortic morphology and the level of aortic oxidative
stress.
Alterations in aortic tunica media thickness and
ROS. Our results concur with previous studies
that showed an increase in tunica media thickness
associated with advancing age [16, 17]. It has been
generally accepted that increases in vascular ROS
are linked to vascular smooth muscle cellular
(VSMC) proliferation and hypertrophy [18-23],
and therefore may act as a hypertrophic/hyperplastic effector to thicken the arterial wall. This possibility is important as increases in wall thickness are
often associated with increased vessel stiffness, a
primary risk factor for the development of hypertension [24, 25]. Herein, we observed that
paracetamol treatment appears to significantly decrease age-related increases in aortic wall thickness
(Figure 1). Whether this decrease in aortic wall

Paracetamol Effects on ROSin Aging Rat Aorta

thickening with paracetamol is due to diminished
VSMC hypertrophy or replication is currently
unclear.
In the present study we used dihydroethidium
(HE) staining of the aortic cross sections to examine the efficacy of paracetamol treatment in attenuating aortic ROS levels [26]. Our data suggest that
aging in FBN rat aortae is characterized by a
marked elevation in the level of superoxide anion
(02 · -) and that the amount of superoxide anion
elevation is unaltered with paracetamol treatment
(Figure 2). In addition to superoxide levels, other
ROS indices include the level of protein oxidation.
Because of its highly diffusible nature across phospholipid membranes [27], peroxynitrite is known
to initiate oxidative modification of proteins. In
our present study, protein oxidation in the rat aortae (as determined by OxyBloC analysis) was
found to be elevated with age, a finding consistent
with previously reported data [28]. The elevation
in the protein oxidation was decreased with
paracetamol treatment (Figure 3). Although we
suspect that decreases in protein oxidation with
paracetamol treatment can be attributed to the antioxidant properties of the paracetamol molecule,
why paracetamol decreases protein oxidation levels
but not the amount of superoxide remains unclear.

Alterations in AMPK activity with age and
paracetamol treatment. AMP-activated protein
kinase (AMPK) is a stress-activated protein kinase
that functions as a metabolic sensor of cellular ATP
levels. Several investigators have shown that AMPK
is also a redox-sensitive enzyme [29, 30]. AMPK is
thought to be activated by phosphorylation when
the ratio of ATP: ADP falls. Once activated,
AMPK switches on catabolic pathways that generate ATP while switching off ATP-consuming processes such as protein synthesis [31]. Our data suggest that aging is associated with a decrease in
AMPK-a (Thr 172) phosphorylation. The decrease
in AMPK-a (Thr 172) phosphorylation we show
with aging is similar to the change in AMPK phosphorylation one would expect to see in cells undergoing hypertrophy [32]. With paracetamol treatment, the level of AMPK-a (Thr 172)
phosphorylation appears to increase (Figure 4).
This increase in the phosphorylation of AMPK-a
(Thr 172) would be expected to decrease protein
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Figure 6. Aging and paracetamol treatment alters
pliosphorylation status of signalin_g proteins p38,
p44!p42 (ERK 112)- MAPK-, and ]nk- MAPK in
F34J/N X BN rat aortae. Protein isolates from the aortae excised from 6-month old and 33-month old control
and 33-month old paracetamol-treated F344/N X BN
rats were analyzed by immunoblotting for changes in
phosphorylated p38, p44/p42 (ERK 1/2), and ]nK protein expression. Data are presented as means ± SE.
Insets: representative blots for phosphorylated p38. An
asterisk (*) indicates significant difference from the
6-month old control value, p < 0.05, (t) indicates significant difference from the 33-month old control value
(P<0.05). n = 8 for all groups.

synthesis and may have contributed, at least in
part, to the diminished aortic wall thickening we
see with paracetamol treatment.

Alterations in the regulation ofMAPK and the
Bax I Bcl-2 ratio with acetaminophen treatment. The mitogen-activated protein kinase
(MAPK) family has been shown to be activated by
exogenous H 2 0 2 and by endogenously-generated
ROS in VSMCs stimulated with growth factors
[23]. The extracellular-signal-regulated kinase
(ERK)-MAPK proteins play a major role in cell
proliferation and differentiation, as well as survival
[33]. The ROS sensitivity of MAPK proteins has
been subject to controversy, since some groups have
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cell proliferation by elevating ERK1/2 MAPK activity. This up-regulation ofERK1/2 MAPK activity could potentially lead to an up-regulation of
p21 and the inhibition of VSMC proliferation,
thereby preventing vascular wall thickening. Future
experiments designed to directly test this assertion
will no doubt be useful in determining whether
this mechanism actually exists.
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Figure 7. Aging and paracetamol treatment alters
basal levels ofapoptottc regulators BAX and Bcl2 in
F344/N X BN rat aortae. Protein isolates from the aortae excised from 6-month old and 33-month old control
and 33-month old paracetamol-treated F344/N X BN
rats were analyzed by immunoblotting for changes in
BAX and Bcl-2 protein expression. Data are presented as
means ± SE. Insets: representative blots for BAX and Bcl2. An asterisk (*) inaicates significant difference from
the 6-month old control value, p < 0.05, (t) indicates
significant difference from the 33-month old control
value (P<O. 05). n = 8 in all groups.

found these proteins to be sensitive [34, 35] while
others have found them to be insensitive [36, 37].
In our present study, the amount of phosphorylated
ERK1/2- and c-Jun N-terminal kinase (JNK) MAPK, but not p38, were lowered with age but
increased with paracetamol treatment (Figure 6).
The reason(s) for which paracetamol may increase
the phosphorylation of MAPK proteins in the aging FBN aorta is currently not clear. Given that
increases in MAPK phosphorylation have been implicated in the initiation of cellular apoptosis, it is
possible that the treatment-induced decreases in
aortic wall thickness we observed may be related to
increased levels of age-related VSMC apoptosis.
The over-proliferation ofVSMCs has been posited
to play a role in the development of several cardiovascular disorders. Reduced MAPK activity can
lead to the down-regulation of the cyclin-dependent kinase (cdk) inhibitor p21 which, in turn, can
cause VSMC proliferation and hypertrophy [38].
Our data indicate that paracetamol may regulate

It is well established that increased aortic wall
thickening can cause an increase in vessel stiffness,
a primary risk factor for the development of hypertension [24, 25]. To investigate the possibility that
paracetamol diminishes age-associated aortic wall
thickening by causing increased levels of apoptosis,
we examined how paracetamol treatment affected
the ratio of Bcl-2 to Bax. Bcl-2 is an evolutionary
conserved protein that blocks apoptosis [39].
Conversely, Bax is a pro-apoptotic signaling protein of the Bcl-2 family that has been proposed to
promote cell death by dimerizing anti-apoptotic
proteins. It is thought that the susceptibility of a
cell to apoptotic signals is regulated by the ratio of
anti- to pro-apoptotic proteins [40, 41]. In the present study, we observed that paracetamol treatment
decreased the amount of Bcl-2, a finding which is
consistent with an increase in VSMC apoptosis.
Whether these changes are directly related to the
decrease in aortic thickness seen with paracetamol
treatment is currently unclear.
In summary, our data indicate that paracetamol
treatment decreases age-associated increases in aortic wall thickening and protein oxidation. These
changes were associated with alterations in AMPK
and MAPK signaling and are consistent with the
anti-oxidant properties of paracetamol. Further experiments will be necessary to determine the exact
mechanisms through which paracetamol may act
to improve vascular health during aging.
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